Shantou Ultrasonic Instrument Research Institute Co., Ltd. (hereinafter referred to as "the Company") held the 12th meeting of the second board of directors on April 27, 2026, and approved the proposal on the use of raised funds to replace self-funded investments in fundraising projects. The relevant information is announced as follows:
1. Basic Information on Raised Funds
According to the approval from the China Securities Regulatory Commission regarding the registration of the Company's initial public offering of stock (Zheng Jian Xu Ke [2024] No. 1391), the Company has completed its initial public offering of 64,249,446 ordinary shares (A shares) at an issue price of RMB 6.70 per share, raising a total of RMB 430,471,288.20. After deducting issuance costs of RMB 46,108,086.88 (excluding tax), the actual net amount raised is RMB 384,363,201.32, which was transferred to the Company's designated account on January 17, 2025. Huaxing Accounting Firm (Special General Partnership) conducted a verification of the funds raised from the public offering and issued a "Verification Report" (Huaxing Yan Zi [2025] No. 21001371272) on January 17, 2025. The Company has stored the raised funds in a special account and signed a "Tripartite Supervision Agreement on the Storage of Raised Funds" with the sponsor and the bank where the raised funds are held.
2. Basic Information on Investment Projects of Raised Funds
- According to the "Prospectus for the Initial Public Offering of Stock and Listing on the Growth Enterprise Market of Shantou Ultrasonic Instrument Research Institute Co., Ltd.", the specific investment projects funded by the raised funds are as follows:
| No. | Project Name | Project Investment Amount (10,000 RMB) | Amount of Raised Funds to be Invested (10,000 RMB) |
|---|---|---|---|
| 1 | Medical Imaging Product R&D and Industrialization Project | 12,860.21 | 12,860.21 |
| 2 | Industrial Non-Destructive Testing System R&D Project | 5,621.20 | 5,621.20 |
| 3 | Portable DR System R&D, Industrialization, and Market Development Project | 9,186.34 | 9,186.34 |
| 4 | Innovation Base Construction Project | 3,478.00 | 3,478.00 |
| Total | 31,145.75 | 31,145.75 |
- On April 27, 2025, the Company held the 8th meeting of the second board of directors and the 5th meeting of the second supervisory board, where the proposal to adjust the internal structure, implementation progress, and use plan of the raised funds was approved. This proposal was also approved by the 2024 annual shareholders' meeting. The Company and all members of the board guarantee that the content of the information disclosure is true, accurate, and complete, with no false records, misleading statements, or significant omissions.
The adjusted usage of raised funds (including excess raised funds) is shown in the table below: